Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CALL
NXP Semiconductors
NXPI
$60.4B
| $2.69M | ﹤0.01% |
+17,000
| New | +$2.7M |
|
2002
Planet Fitness
PLNT
$3.96B
| $2.68M | ﹤0.01% |
34,071
+15,267
| +81% | +$1.07M |
|
|
AXON
2003
Axon Enterprise
AXON
$46.4B
| $2.68M | ﹤0.01% |
16,148
-18,724
| -54% | -$2.96M |
|
2004
Signet Jewelers
SIG
$3.76B
| $2.68M | ﹤0.01% |
39,379
-176,931
| -82% | -$11.3M |
|
2005
JetBlue
JBLU
$2.29B
| $2.68M | ﹤0.01% |
413,214
-162,261
| -28% | -$1.19M |
|
2006
PUT
Cleveland-Cliffs
CLF
$6.99B
| $2.68M | ﹤0.01% |
+166,200
| New | +$2.5M |
|
|
KDNY
2007
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.67M | ﹤0.01% |
101,941
+9,670
| +10% | +$214K |
|
2008
EXL Service
EXLS
$5.29B
| $2.67M | ﹤0.01% |
78,775
+36,345
| +86% | +$1.26M |
|
2009
Fate Therapeutics
FATE
$326M
| $2.66M | ﹤0.01% |
263,875
+84,960
| +47% | +$1.6M |
|
2010
Allogene Therapeutics
ALLO
$694M
| $2.66M | ﹤0.01% |
423,053
+105,287
| +33% | +$975K |
|
|
CALY
2011
PUT
Callaway Golf Company
CALY
$3.14B
| $2.66M | ﹤0.01% |
+134,700
| New | +$2.65M |
|
2012
PUT
Roku
ROKU
$22.7B
| $2.66M | ﹤0.01% |
+65,300
| New | +$3.41M |
|
|
LSXMA
2013
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.66M | ﹤0.01% |
91,960
-3,763
| -4% | -$115K |
|
|
UCB
2014
United Community Banks
UCB
$4.28B
| $2.65M | ﹤0.01% |
78,541
+26,745
| +52% | +$970K |
|
2015
CALL
Plug Power
PLUG
$3.04B
| $2.65M | ﹤0.01% |
+214,600
| New | +$3.42M |
|
|
MTVC
2016
DELISTED
Motive Capital Corp II
MTVC
| $2.65M | ﹤0.01% |
259,245
| – | – |
|
|
CCAI
2017
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
| $2.65M | ﹤0.01% |
264,116
| – | – |
|
2018
Marqeta
MQ
$1.66B
| $2.65M | ﹤0.01% |
108,267
+27,941
| +35% | +$763K |
|
2019
Evolent Health
EVH
$444M
| $2.64M | ﹤0.01% |
94,142
+58,588
| +165% | +$1.68M |
|
2020
Cavco Industries
CVCO
$4.55B
| $2.63M | ﹤0.01% |
11,646
+2,784
| +31% | +$618K |
|
2021
PUT
Skyworks Solutions
SWKS
$10.6B
| $2.63M | ﹤0.01% |
+28,900
| New | +$2.59M |
|
2022
CALL
Duke Energy
DUK
$97.3B
| $2.63M | ﹤0.01% |
+25,500
| New | +$2.45M |
|
|
EVA
2023
DELISTED
Enviva Inc.
EVA
| $2.62M | ﹤0.01% |
49,442
+37,887
| +328% | +$2.17M |
|
2024
H.B. Fuller
FUL
$3.28B
| $2.61M | ﹤0.01% |
36,490
+1,695
| +5% | +$122K |
|
|
ITAQ
2025
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
| $2.61M | ﹤0.01% |
256,524
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.